Tissue plasminogen activator (alteplase) treatment for femoral artery thrombosis after cardiac catheterisation in infants and children.

@article{Zenz1993TissuePA,
  title={Tissue plasminogen activator (alteplase) treatment for femoral artery thrombosis after cardiac catheterisation in infants and children.},
  author={Wilhelm Zenz and Wolfgang Muntean and Albrecht Beitzke and Gefried Zobel and Michael Riccabona and Andreas Gamillscheg},
  journal={British heart journal},
  year={1993},
  volume={70 4},
  pages={
          382-5
        }
}
OBJECTIVE To determine the efficacy of fibrinolytic therapy with tissue plasminogen activator (alteplase) in infants and children with arterial thrombosis after cardiac catheterisation. DESIGN Use of alteplase (Actilyse) in a protocol with prospective data collection. Alteplase was administered to infants and children with arterial thrombosis after cardiac catheterisation. A dose of 0.5 mg/kg/h was given continuously via a peripheral vein for the first hour followed by 0.25 mg/kg/h till clot… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 26 REFERENCES

Kompli - kationen bei zwei Serien von je 1000 Herzkatheteruntersuchungen im Kindesalter

A Beitzke, CJ Mache
  • Wien Kin Wochenschr
  • 1991

A comparison between heparin and low - dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction

WP Hamilton, N Kleiman
  • N EnglJ Med
  • 1990

Therapeutical aspects in arterial and venous thrombosis in children

W Kreuz, U Nowak-Gottl, D Schwabe, B Stover
  • Blut
  • 1989

Similar Papers

Loading similar papers…